Dialforhealth Greencross Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 04-12-2024
- Paid Up Capital ₹ 2.50 M
as on 04-12-2024
- Company Age 19 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 72.00%
(FY 2022)
- Ebitda 72.00%
(FY 2022)
- Net Worth -1.71%
(FY 2022)
- Total Assets -5.12%
(FY 2022)
About Dialforhealth Greencross
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Harish Sadana, Nitinkumar Parekh, and Chimanlal Patel serve as directors at the Company.
- CIN/LLPIN
U51397GJ2005PLC061284
- Company No.
061284
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Jul 2005
- Date of AGM
31 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dialforhealth Greencross?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nitinkumar Parekh | Director | 03-Dec-2012 | Current |
Harish Sadana | Nominee Director | 08-Jul-2005 | Current |
Chimanlal Patel | Director | 12-Sep-2018 | Current |
Financial Performance and Corporate Structure Insights of Dialforhealth Greencross.
Dialforhealth Greencross Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 72% increase in profit. The company's net worth dipped by a decrease of 1.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Dialforhealth Greencross?
In 2021, Dialforhealth Greencross had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Zydus Healthcare LimitedActive 35 years 4 months
Harish Sadana and Nitinkumar Parekh are mutual person
- Zydus Animal Health And Investments LimitedActive 6 years 7 months
Nitinkumar Parekh and Chimanlal Patel are mutual person
- Zydus Strategic Investments LimitedActive 4 years 5 months
Harish Sadana and Nitinkumar Parekh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dialforhealth Greencross?
Unlock and access historical data on people associated with Dialforhealth Greencross, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dialforhealth Greencross, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dialforhealth Greencross's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.